| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LENZ Therapeutics, Inc. | President, CEO and Secretary, Director | Common Stock | 45K | $93.6K | $2.08 | Jul 22, 2024 | Direct |
| LENZ Therapeutics, Inc. | President, CEO and Secretary, Director | Stock Option (right to buy) | 342K | Jul 22, 2024 | Direct | ||
| Contineum Therapeutics, Inc. | Director | Stock Option (right to buy) | 29.5K | May 24, 2024 | Direct | ||
| iBio, Inc. | Director | Stock Option (right to buy) | 18.9K | Nov 21, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| IBIO | iBio, Inc. | Nov 21, 2024 | 1 | $0 | 4 | Nov 25, 2024 | Director |
| GRPH | LENZ Therapeutics, Inc. | Jul 22, 2024 | 2 | $46.8K | 4 | Jul 23, 2024 | President, CEO and Secretary, Director |
| CTNM | Contineum Therapeutics, Inc. | May 24, 2024 | 1 | $0 | 4 | May 29, 2024 | Director |
| CTNM | Contineum Therapeutics, Inc. | Apr 4, 2024 | 0 | $0 | 3 | Apr 4, 2024 | Director |
| LENZ | LENZ Therapeutics, Inc. | Mar 21, 2024 | 4 | $0 | 4 | Mar 25, 2024 | President, CEO and Secretary, Director |
| LENZ | LENZ Therapeutics, Inc. | Mar 21, 2024 | 0 | $0 | 3 | Mar 25, 2024 | President, CEO and Secretary, Director |
| IBIO | iBio, Inc. | Dec 9, 2021 | 1 | $0 | 4 | Dec 13, 2021 | Director |
| IBIO | iBio, Inc. | Jun 7, 2021 | 1 | $0 | 4 | Jun 9, 2021 | Director |
| IBIO | iBio, Inc. | Jun 7, 2021 | 0 | $0 | 3 | Jun 9, 2021 | Director |